{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:51:18Z","timestamp":1791489078402,"version":"4.3.4"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Institute on Drug Abuse of the National Institutes of Health","award":["R01DA033953"],"award-info":[{"award-number":["R01DA033953"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","drugandalcoholdependence.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.drugalcdep.2017.03.033","type":"journal-article","created":{"date-parts":[[2017,6,27]],"date-time":"2017-06-27T01:45:20Z","timestamp":1498527920000},"page":"307-314","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Association between process measures and mortality in individuals with opioid use disorders"],"prefix":"10.1016","volume":"177","author":[{"given":"Katherine E.","family":"Watkins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Paddock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa J.","family":"Hudson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songthip","family":"Ounpraseuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy M.","family":"Schrader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly A.","family":"Hepner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley D.","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0005","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1001\/archinternmed.2010.541","article-title":"Collaborative care of opioid-addicted patients in primary care using buprenorphine: five-year experience","volume":"171","author":"Alford","year":"2011","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0010","series-title":"Standards and Performance Measures","author":"American Society of Addiction Medicine (ASAM)","year":"2016"},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0015","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1001\/jama.2016.14039","article-title":"Fostering transparency in outcomes, quality, safety, and costs","volume":"316","author":"Austin","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0020","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1080\/08897077.2014.991469","article-title":"Adherence to buprenorphine treatment guidelines in a Medicaid program","volume":"36","author":"Baxter","year":"2015","journal-title":"Subst. Abus."},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0025","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1526-4637.2011.01075.x","article-title":"Societal costs of prescription opioid abuse, dependence, and misuse in the United States","volume":"12","author":"Birnbaum","year":"2011","journal-title":"Pain Med."},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0030","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1046\/j.1360-0443.2002.00179.x","article-title":"An increase in overdose mortality during the first 2 weeks after entering or re-entering methadone treatment in Amsterdam","volume":"97","author":"Buster","year":"2002","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0035","first-page":"1487","article-title":"Vital signs: overdoses of prescription opioid pain relievers\u2013United States, 1999\u20132008","volume":"60","author":"Centers for Disease Control and Prevention (CDC)","year":"2011","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0040","first-page":"133","article-title":"HIV infection and HIV-associated behaviors among injecting drug users \u2212 20 cities, United States, 2009","volume":"61","author":"Centers for Disease Control and Prevention,","year":"2012","journal-title":"MMWR Morbid. Mortal.Wkly. Rep."},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0045","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/pds.1694","article-title":"A systematic review of research examining benzodiazepine-related mortality","volume":"18","author":"Charlson","year":"2009","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0050","series-title":"Advancing Integration of Behavioral Health into Primary Care: A Continuum-Based Framework","author":"Chung","year":"2016"},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0055","doi-asserted-by":"crossref","first-page":"c5475","DOI":"10.1136\/bmj.c5475","article-title":"Risk of death during and after opiate substitution treatment in primary care: prospective observational study in UK General Practice Research Database","volume":"341","author":"Cornish","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0060","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/add.13087","article-title":"Risk of mortality on and off methadone substitution treatment in primary care: a national cohort study","volume":"111","author":"Cousins","year":"2016","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0065","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/CIRCOUTCOMES.110.957951","article-title":"Landmark analysis at the 25-year landmark point","volume":"4","author":"Dafni","year":"2011","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0070","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1111\/j.1360-0443.2007.02025.x","article-title":"Risk of fatal overdose during and after specialist drug treatment: the VEdeTTE study, a national multi-site prospective cohort study","volume":"102","author":"Davoli","year":"2007","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0075","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.drugalcdep.2009.05.021","article-title":"Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved","volume":"105","author":"Degenhardt","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0080","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1360-0443.2010.03140.x","article-title":"Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies","volume":"106","author":"Degenhardt","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0085","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1111\/add.12551","article-title":"The global epidemiology and burden of opioid dependence: results from the global burden of disease 2010 study","volume":"109","author":"Degenhardt","year":"2014","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0090","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/add.12337","article-title":"Causes of death in a cohort treated for opioid dependence between 1985 and 2005","volume":"109","author":"Degenhardt","year":"2014","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0095","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","author":"Deyo","year":"1992","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0100","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/archpsyc.58.6.565","article-title":"Quality of medical care and excess mortality in older patients with mental disorders","volume":"58","author":"Druss","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0105","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1111\/j.1532-5415.2011.03586.x","article-title":"Use of opioids or benzodiazepines and risk of pneumonia in older adults: a population-based case-control study","volume":"59","author":"Dublin","year":"2011","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0110","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.2105\/AJPH.2011.300153","article-title":"Why health care process performance measures can have different relationships to outcomes for patients and hospitals: understanding the ecological fallacy","volume":"101","author":"Finney","year":"2011","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0115","first-page":"1","article-title":"Prescription opioid analgesic use among adults: United States, 1999\u20132012","author":"Frenk","year":"2015","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0120","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s11606-015-3571-4","article-title":"The association between receipt of guideline-concordant long-term opioid therapy and all-cause mortality","volume":"31","author":"Gaither","year":"2016","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0125","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/ADM.0000000000000255","article-title":"The effect of substance use disorders on the association between guideline-concordant long-term opioid therapy and all-cause mortality","volume":"10","author":"Gaither","year":"2016","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0130","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0740-5472(02)00303-3","article-title":"Establishing the feasibility of performance measures for alcohol and other drugs","volume":"23","author":"Garnick","year":"2002","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0135","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jsat.2008.06.008","article-title":"Adapting Washington Circle performance measures for public sector substance abuse treatment systems","volume":"36","author":"Garnick","year":"2009","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0140","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1176\/appi.ps.201400393","article-title":"Measuring performance in psychiatry: a call to action","volume":"66","author":"Glied","year":"2015","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0145","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1111\/add.12598","article-title":"The burden of premature opioid-related mortality","volume":"109","author":"Gomes","year":"2014","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0150","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/ADM.0000000000000164","article-title":"Patterns and quality of buprenorphine opioid agonist treatment in a large medicaid program","volume":"9","author":"Gordon","year":"2015","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0155","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.0006-341X.1999.00652.x","article-title":"Predictive margins with survey data","volume":"55","author":"Graubard","year":"1999","journal-title":"Biometrics"},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0160","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s10742-012-0089-7","article-title":"Assessing the sensitivity of treatment effect estimates to differential follow-up rates: implications for translational research","volume":"12","author":"Griffin","year":"2012","journal-title":"Health Serv. Outcomes Res. Methodol."},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0165","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.drugalcdep.2014.03.020","article-title":"Clinical monitoring and high-risk conditions among patients with SUD newly prescribed opioids and benzodiazepines","volume":"142","author":"Grossbard","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0170","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11414-008-9142-2","article-title":"Does meeting the HEDIS substance abuse treatment engagement criterion predict patient outcomes?","volume":"37","author":"Harris","year":"2010","journal-title":"J. Behav. Health Serv. Res."},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0175","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jsat.2015.01.002","article-title":"Examining the specification validity of the HEDIS quality measures for substance use disorders","volume":"53","author":"Harris","year":"2015","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0180","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/ADM.0000000000000203","article-title":"Specifying and pilot testing quality measures for the American society of addiction medicine's standards of care","volume":"10","author":"Harris","year":"2016","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0185","series-title":"Improving the Quality of Health Care for Mental and Substance-Use Conditions","author":"Institute of Medicine,","year":"2006"},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0190","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/0897190013515001","article-title":"Benzodiazepines: a major component in unintentional prescription drug overdoses with opioid analgesics","volume":"27","author":"Jann","year":"2014","journal-title":"J. Pharm. Pract."},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0195","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.drugalcdep.2012.07.004","article-title":"Polydrug abuse: a review of opioid and benzodiazepine combination use","volume":"125","author":"Jones","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0200","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S2215-0366(15)00366-1","article-title":"Mortality risk of opioid substitution therapy with methadone versus buprenorphine: a retrospective cohort study","volume":"2","author":"Kimber","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0205","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S0895-4356(00)00256-0","article-title":"Development of a comorbidity index using physician claims data","volume":"53","author":"Klabunde","year":"2000","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0210","doi-asserted-by":"crossref","first-page":"774","DOI":"10.2105\/AJPH.91.5.774","article-title":"The impact of harm-reduction-based methadone treatment on mortality among heroin users","volume":"91","author":"Langendam","year":"2001","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0215","doi-asserted-by":"crossref","first-page":"948","DOI":"10.2307\/2533848","article-title":"Assessing the sensitivity of regression results to unmeasured confounders in observational studies","volume":"54","author":"Lin","year":"1998","journal-title":"Biometrics"},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0220","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1001\/jamainternmed.2014.5430","article-title":"Outcomes associated with invasive and noninvasive ventilation among patients hospitalized with exacerbations of chronic obstructive pulmonary disease","volume":"174","author":"Lindenauer","year":"2014","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0225","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.2105\/AJPH.2015.302843a","article-title":"Worldwide prevalence and trends in unintentional drug overdose: a systematic review of the literature","volume":"105","author":"Martins","year":"2015","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0230","series-title":"Economic Impact of Integrated Medical-Behavioral Healthcare: Implications for Psychiatry","author":"Melek","year":"2014"},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0235","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1089\/pop.2013.0098","article-title":"Prescription opioid abuse: a literature review of the clinical and economic burden in the United States","volume":"17","author":"Meyer","year":"2014","journal-title":"Popul. Health Manag."},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0240","doi-asserted-by":"crossref","first-page":"727","DOI":"10.2747\/0272-3638.20.8.727","article-title":"Metropolitan, urban, and rural communting areas: toward a better depiction of the U.S. settlement system","volume":"20","author":"Morrill","year":"1999","journal-title":"Urban Geogr."},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0245","doi-asserted-by":"crossref","DOI":"10.15288\/jsad.2017.78.588","article-title":"Association between process-based quality indicators and mortality for patients with substance use disorders","author":"Paddock","year":"2017","journal-title":"J. Stud. Alcohol Drug"},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0250","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1176\/appi.ps.201400589","article-title":"The current state of behavioral health quality measures: where are the gaps?","volume":"66","author":"Patel","year":"2015","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0255","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.drugalcdep.2009.09.013","article-title":"15-year survival and retention of patients in a general hospital-affiliated methadone maintenance treatment (MMT) center in Israel","volume":"107","author":"Peles","year":"2010","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0260","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.drugalcdep.2014.09.782","article-title":"National record linkage study of mortality for a large cohort of opioid users ascertained by drug treatment or criminal justice sources in England, 2005\u20132009","volume":"146","author":"Pierce","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0265","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/add.13193","article-title":"Impact of treatment for opioid dependence on fatal drug-related poisoning: a national cohort study in England","volume":"111","author":"Pierce","year":"2016","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0270","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1176\/appi.ps.201400461","article-title":"How can we link general medical and behavioral health care? international models for practice and policy","volume":"66","author":"Pincus","year":"2015","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0275","series-title":"Principles of Addiction Medicine","author":"Ries","year":"2009"},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0280","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/ADM.0000000000000151","article-title":"Correlates of opioid use in adults with self-reported drug use recruited from public safety-net primary care clinics","volume":"9","author":"Ries","year":"2015","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0285","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1377\/hlthaff.2015.1424","article-title":"Hospitalizations related to opioid abuse\/dependence and associated serious infections increased sharply, 2002\u201312","volume":"35","author":"Ronan","year":"2016","journal-title":"Health Aff. (Millwood)"},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0290","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.15585\/mmwr.mm6450a3","article-title":"Increases in drug and opioid overdose deaths\u2013United States, 2000","volume":"64","author":"Rudd","year":"2016","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0295","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.15585\/mmwr.mm655051e1","article-title":"Increases in drug and opioid-involved overdose deaths\u2013United States: 2010\u20132015","volume":"65","author":"Rudd","year":"2016","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0300","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s11606-009-1218-z","article-title":"Relationship of opioid use and dosage levels to fractures in older chronic pain patients","volume":"25","author":"Saunders","year":"2010","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0305","doi-asserted-by":"crossref","first-page":"737","DOI":"10.2105\/AJPH.2010.197038","article-title":"Surviving drug addiction: the effect of treatment and abstinence on mortality","volume":"101","author":"Scott","year":"2011","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0310","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1478-7954-4-2","article-title":"Accuracy and completeness of mortality data in the Department of Veterans Affairs","volume":"4","author":"Sohn","year":"2006","journal-title":"Popul. Health Metr."},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0315","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.drugalcdep.2011.10.016","article-title":"The impact of buprenorphine on treatment of opioid dependence in a Medicaid population: recent service utilization trends in the use of buprenorphine and methadone","volume":"123","author":"Stein","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0320","first-page":"1","article-title":"Opioid analgesic and benzodiazepine prescribing among Medicaid-enrollees with opioid use disorders: the role of provider communities","volume":"22","author":"Stein","year":"2016","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0325","series-title":"The Surgeon General's Call to End the Opioid Crisis","author":"Surgeon General of the United States","year":"2016"},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0330","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000446429","article-title":"Methadone-related overdose deaths in a liberal opioid maintenance treatment programme","volume":"22","author":"Tjagvad","year":"2016","journal-title":"Eur. Addict. Res."},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0335","unstructured":"U.S. Department of Health and Human Services, Agency for Healthcare Research and Quality, n.d. Substance Use Treatment Programs\/Centers. https:\/\/www.qualitymeasures.ahrq.gov\/search?f_Measurement_Setting=Substance+Use+Treatment+Programs%2fCenters&fLockTerm=Substance+Use+Treatment+Programs%2fCenters). Accessed on October 4 2016."},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0340","unstructured":"U.S. Department of Veterans Affairs, VA\/DoD clinical practice guidelines: Management of substance use disorder (SUD) (2016); page 106. http:\/\/www.healthquality.va.gov\/guidelines\/MH\/sud\/. Accessed on 3 October 2016."},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0345","series-title":"Calculating a Comorbidity Index for Risk Adjustment Using VA or Medicare Data","author":"VA Information Resource Center","year":"2014"},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0350","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/j.addbeh.2013.05.008","article-title":"Treatment or high: benzodiazepine use in patients on injectable heroin or oral opioids","volume":"38","author":"Vogel","year":"2013","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0355","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1945-1474.2010.00128.x","article-title":"Developing medical record-based performance indicators to measure the quality of mental healthcare","volume":"33","author":"Watkins","year":"2011","journal-title":"J. Healthc. Qual."},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0360","series-title":"Veterans Health Administration Mental Health Program Evaluation: Capstone Report (TR-956)","author":"Watkins","year":"2011"},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsat.2016.06.001","article-title":"Association between quality measures and mortality in individuals with co-occurring mental health and substance use disorders","volume":"69","author":"Watkins","year":"2016","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0370","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/QAI.0000000000000591","article-title":"Long-term prescription of opioids and\/or benzodiazepines and mortality among HIV-infected and uninfected patients","volume":"69","author":"Weisberg","year":"2015","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0375","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1258\/jhsrp.2008.008039","article-title":"Reconstructing continuity of care in mental health services: a multilevel conceptual framework","volume":"14","author":"Wierdsma","year":"2009","journal-title":"J. Health Serv. Res. Policy"},{"key":"10.1016\/j.drugalcdep.2017.03.033_bib0380","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1001\/archinternmed.2009.357","article-title":"Meta-analysis of the impact of 9 medication classes on falls in elderly persons","volume":"169","author":"Woolcott","year":"2009","journal-title":"Arch. Intern. Med."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871617302235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871617302235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T19:11:41Z","timestamp":1602357101000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871617302235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":76,"alternative-id":["S0376871617302235"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.03.033","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between process measures and mortality in individuals with opioid use disorders","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.03.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}